A Study of HS-10529 in KRAS G12D Patients With Advanced Solid Tumors
Clinical trial NCT06963398 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06963398
- Sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-15
- Primary completion
- 2029-04-30
- Enrollment
- 520
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.